Hodgkin lymphoma trials in Denmark
6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Where
- Copenhagen Oe
- Age
- Up to 17 years
- People
- 37 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2023-504264-41-00 · EU 2023-504264-41-00 - Phase 1Enrolling by invitationA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Copenhagen Oe, Odense C
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - Phase 2Taking peopleSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Where
- Copenhagen Oe, Vejle
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00 - No phaseTaking peopleProton Therapy for Mediastinal Lymphoma (PROMLY)
- Where
- Copenhagen
- Age
- 18 years and over
- People
- 139
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT07817641 - Phase 3Taking peopleBrentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Where
- Aarhus N, Copenhagen Oe
- Age
- 16 years to 69 years
- People
- 1,042 worldwide
- Run by
- University College, London
See details and how to joinNCT04685616 · EU 2022-500031-37-00 - No phaseTaking peopleInvestigating Cognitive Impairment in Young Patients With Cancer Prospectively
- Where
- Copenhagen
- Age
- 7 years to 29 years
- People
- 100
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT05840575